2012 Pfizer Fellowships in Public Health
The Fellowship in Public Health is intended to support research that fosters academic science, knowledge of public health, and collaborative partnerships between accredited schools or programs of public health and federal, state, and local departments of public health. Institutions interested in this fellowship program must submit research proposals for programs or initiatives that involve chronic disease prevention (e.g., smoking cessation), healthcare costs (e.g., economic costs of counterfeit medicines), preventive medicine, and/or public health preparedness.
Funds Available
One award of up to $100,000, paid over 2 years at $50,000 per year
Application Deadline: February 10, 2012
Awards Announced: By April 1, 2012
Funding Begins: July 2012
Eligibility
Institutions
Must be an accredited US-based academic institution
Must not be located in the State of Vermont
The institution cannot host another recipient of this same award during the proposed term
Senior staff, division heads or department chairs should work on behalf of their institution to prepare and submit an application for consideration
Proposal
Proposals requesting to study any pharmaceutical product are ineligible for MAP awards. Requests to study Pfizer products must to be submitted through our Investigator Initiated Research portal (http://www.pfizer.com/research/investigator/investigator_initiated_research.jsp).
Basic science and/or fundamental research (animal model, in-vivo / in-vitro) are not permissible
Proof of harm or otherwise highly invasive studies (unethical) will not be considered
Fellows
Prospective fellows at the institution CANNOT apply directly for the award. A Fellow may assist the senior staff, division head or department chair at the institution in the development of the grant application
A fellow supported by a Pfizer MAP fellowship must have the opportunity to carry out supervised biomedical or clinical research with the primary objective of preparing them for their respective discipline and subspecialty
Upon receipt of the grant award, the Fellow selected by the Institution must meet the following criteria:
US citizen or foreign national with permanent US residence
Hold an advanced degree (i.e., MD, DO, NP, PharmD, etc.)
Be enrolled in fellowship program (Clinical award recipients)
Hold a non-tenured, junior faculty appointment (Research award recipients)
Selection Process
Quality of the Research Proposal:
Is the proposal innovative, significant, and feasible, and does it have depth?
Does the proposal reference interdisciplinary knowledge?
Does the proposal bridge the academic and practice communities?
Quality of the Institution:
Assessment of the academic and/or medical facilities and the institution's commitment to research.
Are the institutional support, equipment and other physical resources available to the fellow(s) adequate for the proposed project?
Will the project benefit from the unique features of the environment, subject populations, or collaborative arrangements offered by the institution?
Quality of the Mentor(s):
Is the mentor(s) well suited to the project?
What is the mentor(s) experience within the field?
Is the mentoring relationship beneficial for the development of potential fellow?
Contact Us
Questions about the programs and/or applications:
The Pfizer MAP Team
Phone: (877) 254-6953
E-mail: MAPinfo@clinicalconnexion.com
